Literature DB >> 8813046

Therapy for human immunodeficiency virus infection -- what have we learned?

L Corey, K K Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8813046     DOI： 10.1056/NEJM199610103351509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Treatment of chronic hepatitis B: new antiviral therapies.

Authors:  F Yao; R G Gish
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

2.  Ethical challenges posed by clinical progress in AIDS.

Authors:  R Bayer; J Stryker
Journal:  Am J Public Health       Date:  1997-10       Impact factor: 9.308

Review 3.  Janus considers the HIV pandemic--harnessing recent advances to enhance AIDS prevention.

Authors:  M E St Louis; J N Wasserheit; H D Gayle
Journal:  Am J Public Health       Date:  1997-01       Impact factor: 9.308

4.  Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy.

Authors:  M Y Smith; B D Rapkin; A Morrison; S Kammerman
Journal:  J Gen Intern Med       Date:  1997-04       Impact factor: 5.128

Review 5.  Anti-HIV ribozymes.

Authors:  L Q Sun; J A Ely; W Gerlach; G Symonds
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.860
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.